drugset / Trial / NCT00088972

S0300, Celecoxib in Preventing Breast Cancer in Premenopausal Women

NCT00088972 ↗

RandomizedParallel-groupDouble-blindPrevention

Summary

RATIONALE: Chemoprevention therapy is the use of certain drugs to try to prevent the development or recurrence of cancer. The use of celecoxib may be effective in preventing breast cancer. PURPOSE: This randomized phase II trial is studying how well celecoxib works in preventing breast cancer in premenopausal women who are at risk for developing the disease.

Timeline

Start
2004-11
Primary completion
2009-07
Completion
2009-07

Outcome

Outcome not reported

Stopped (Enrollment): “Study closed due to poor accrual.”

Drugs

EvaluationDrugModalityDoseRoute
Subject Celecoxib Other / unclassified — Oral

Indications